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trast, kidney tissue Ang II contents were reduced in theRenal function in the AT1A receptor knockout mouse during
AT1A2/2 mice and were not significantly altered during vol-normal and volume-expanded conditions.
ume expansion in either the AT1A2/2 or the AT1A1/1 mice.Background. Genetically altered mice lacking the AT1A an-
Conclusions. The absence of AT1A receptors does not impairgiotensin II (Ang II) receptor were used to examine the role
chronic regulation of renal blood flow, GFR, or glomerulotubu-of AT1A receptors in regulating renal hemodynamics, sodium
lar balance. The prompt restoration of MAP following volumeexcretion, glomerulotubular balance, and Ang II levels in
expansion suggests that low blood pressure in the AT1A recep-plasma and kidney during normal and volume-expanded condi-
tor-deficient mice is primarily due to reduced effective plasmations.
and extracellular fluid volume. Normalization of plasma AngMethods. AT1A receptor-deficient mice and their wild-type
II levels with volume expansion demonstrates a dominant effectcontrols were anesthetized with inactin and ketamine, and were
prepared to allow intravenous infusions of solutions and mea- of extracellular fluid volume and blood pressure over AT1A
surements of aortic pressure and urine collections. Inulin and receptor-mediated short-loop feedback in the regulation of
para-aminohippurate (PAH) solutions were infused intrave- plasma Ang II levels.
nously for clearance determinations under conditions of euvo-
lemia (2.5 ml/min infusion of isotonic saline) or volume-expan-
sion conditions (12.5 ml/min). After three 30-minute urine
It is well recognized that the renin-angiotensin systemcollections, blood samples were collected, and kidneys were
(RAS) plays a critical role in the normal regulation ofharvested. Plasma and kidney Ang II measurements were made
by radioimmunoassay. arterial blood pressure, extracellular fluid volume
Results. In the euvolemic state, mean arterial pressures (ECFV), and renal hemodynamic and excretory func-
(MAPs) were significantly lower in the AT1A receptor-deficient tion, and that inappropriate activation of this powerfulmice (68 6 4 mm Hg) compared with wild-type controls (89 6
system contributes importantly to the pathophysiology3 mm Hg). Despite the lower MAP, the glomerular filtration
of several forms of hypertension [1]. Angiotensin II (Angrate (GFR), renal plasma flow (RPF), absolute sodium excre-
tion, and fractional sodium excretion were not significantly II) is functionally the most relevant peptide of this sys-
different between wild-type and AT1A2/2 mice. Volume tem, and most of its physiological effects are mediated
expansion did not alter MAP in wild-type mice, but significantly
via activation of Ang II type 1 (AT1) receptors [2, 3].increased MAP in the AT1A2/2 mice (68 6 4 to 83 6 5 mm Hg).
The recent successful disruption of the AT1A receptorSimilar increases in GFR, RPF, absolute sodium excretion, and
fractional sodium excretion in AT1A1/1 and AT1A2/2 mice gene and the development of AT1A receptor knockout
were observed. Glomerulotubular balance was not disrupted mice (AT1A2/2) have provided novel means to evaluate
by the absence of AT1A receptors. During euvolemia, plasma the role of AT1A receptors in the regulation of bloodAng II concentrations were significantly higher in the AT1A2/2 pressure, ECFV, renal function, and renal developmentmice compared with wild-type mice (536 6 172 vs. 198 6 36
[4, 5]. The AT1A2/2 mice do not exhibit major survivalfmol/ml). Although volume expansion had no effect on plasma
Ang II levels in the AT1A1/1 group, plasma Ang II concentra- or kidney developmental problems [5]; however, disrup-
tions were markedly suppressed in the AT1A2/2 mice to levels tion of the AT1A receptor gene has been shown to result
that were not different from those in wild-type mice. In con- in reduced arterial blood pressure [4]. In the absence of
AT1A receptors, AT1B receptors may partially replace the
function of AT1A receptors in blood pressure regula-Key words: renin-angiotensin system, angiotensin II, extracellular vol-
ume, glomerular filtration rate, glomerulotubular balance. tion [6].
AT1A2/2 mice have been found to exhibit impairedReceived for publication January 12, 1999
urine concentrating ability (abstract; Oliverio et al, J Amand in revised form May 21, 1999
Accepted for publication June 28, 1999 Soc Nephrol 9:S383, 1998) and attenuated tubuloglomer-
ular feedback (TGF) responses [7]. Considering the fact 1999 by the International Society of Nephrology
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that the TGF mechanism is important for the regulation Renal function studies
of renal blood flow (RBF) and glomerular filtration rate On the day of experiment, male AT1A2/2 and
(GFR) [8, 9], and that the control of GFR and solute AT1A1/1 mice weighing 26 to 36 g were anesthetized with
reabsorption are crucial elements in the contribution a combination of Inactin (thiobutabarbital sodium, 100
made by the kidney to ECFV homeostasis [10, 11], the mg/kg, intraperitoneally) and Ketalar (ketamine, 10 mg/kg,
capability of the AT1A2/2 mice to regulate ECFV ho- intraperitoneally). Supplemental doses of anesthesia
meostasis under stress conditions and in response to (ketamine, 5 mg/kg) were administered intramuscularly
acute volume increases remains unclear. Furthermore, as required. The mice were placed on a servo-controlled
the AT1 receptor, which is abundant on the luminal sur- surgical table that maintained body temperature at 378C,
face of the proximal and distal nephron segments [12], and tracheostomy was performed using PE-90 tubing.
has been suggested as a major contributor to glomerulo- As in previous experiments performed on anesthetized
tubular balance following volume expansion [13, 14]. rats [19], the mice were allowed to breathe air enriched
Thus, this study was performed to compare renal hemo- with O2 by placing the exterior end of the tracheal can-
dynamic and excretory function in mice lacking Ang II nula inside a small plastic chamber into which humidified
AT1A receptors (AT1A2/2) with their wild-type controls 95% O2/5% CO2 was continuously passed. The right
(AT1A1/1) during euvolemic conditions and during carotid artery was cannulated with PE-10 tubing for con-
acute isotonic saline volume expansion. In view of the tinuous arterial blood pressure measurement and blood
growing awareness of the organ-specific role of Ang II sampling. Blood pressure was monitored with a Statham
as a paracrine factor, and the observation that intrarenal pressure transducer (model P23DC) and recorded on a
Ang II levels can be dissociated from circulating levels computer (model P5-166; Gateway 2000, North Sioux
[15–17], as well as the recent evidence that total kidney City, SD, USA) using a computerized data-acquisition
tissue Ang II content is determined, at least in part, by system (MP100 System; BIOPAC Systems, Inc., Goleta,
AT1 receptor-mediated binding and internalization of CA, USA) with the “AcqKnowledge” software package
circulating Ang II [16, 18], we also characterized plasma (version 3.2.4.; BIOPAC). The right jugular vein was
and kidney tissue Ang II levels in AT1A2/2 mice under catheterized with PE-10 tubing for fluid infusion. The
control and volume-expanded conditions.
bladder was catheterized via a suprapubic incision with
PE-50 tubing to allow timed urine collections. During
METHODS surgery, an isotonic saline solution containing 6% albu-
min (bovine; Sigma Chemical, St. Louis, MO, USA) wasThe studies described here were performed in accor-
infused at a rate of 2.5 ml/min. After surgery, the intrave-dance with the guidelines and practices established by
nous infusion was changed to isotonic saline containingthe Tulane University School of Medicine Animal Care
1% albumin, 7.5% polyfructosan (Inutest; Laevosan,and Use Committee.
Linz/Donau, Austria), and 1.5% para-aminohippurate
Animals (PAH; Merck Sharp & Dohme, West Point, PA, USA)
and infused at the same rate. To determine the functionalMice lacking AT1A receptors for Ang II (AT1A2/2)
absence of AT1A receptors, the blood pressure responseswere generated using homologous recombination in em-
to intravenous bolus injections of 100 ng of Ang II werebryonic stem cells as described previously [4]. The mice
evaluated. Renal function was determined in AT1A1/1used in the study were F2 progeny derived from crosses
and AT1A2/2 mice (N 5 9 and 8, respectively) duringof (1293C57BL/6)F1 AT1A1/2 parents. Such crosses
control euvolemic conditions (intravenous infusion rateyield litters containing both 1/1 and 2/2 animals, and
of 2.5 ml/min) and in separate groups of AT1A1/1 (N 5 5)thus, the mice used for experiments were often litter-
and AT1A2/2 (N 5 5) mice during isotonic saline volumemates. Because this F2 generation of AT1A1/1 and 2/2
expansion (intravenous infusion rate of 12.5 ml/min formice possess similar, random assortments of background
a total infusion of approximately 5% of body weight).genes from the parental strains, these 1/1 animals are
After a 60-minute equilibration period, three consecu-better experimental controls than either inbred C57BL/6
tive 30-minute urine collections and an arterial bloodor 129 mice. Differences in phenotype observed across
sample (300 ml) were obtained to determine whole kid-a population of such F2 animals are therefore due to
ney hemodynamic and excretory function. The arterialdifferences in the disrupted gene. The animals were bred
blood sample was obtained immediately following theand maintained in the animal facility of the Durham
completion of the three urine collections in order toVeterans Affairs Medical Center and transported to the
avoid reducing the mean arterial blood pressure duringanimal facility of Tulane Medical School one to two
the course of the clearance measurements. An additionalweeks prior to the acute experiments. The animal geno-
blood sample (700 ml) was collected into chilled metha-types were determined by Southern blot analysis of DNA
isolated from the tail. nol, and the kidneys and heart were excised, drained,
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weighed, and homogenized in chilled methanol for deter-
mination of plasma and kidney tissue Ang II levels by
radioimmunoassay.
Analytical procedures and statistical analyses
The blood samples and the kidney and heart homoge-
nates were centrifuged at 48C for 10 minutes. The super-
natants were dried overnight in a vacuum centrifuge
(Savant, Hicksville, NY, USA). The dried residues were
reconstituted in 4 ml of 50 mm sodium phosphate buffer
(pH 7.4) containing 0.1% bovine serum albumin and
then extracted as described and validated previously [20–
22]. Briefly, the reconstituted plasma samples and kidney
and heart extracts were applied to a phenyl-bonded solid
phase extraction (SPE) column (Bond-Elut; Analyt-
ichem, Harbor City, CA, USA) that had been prewashed
with methanol (3 ml) followed by water (6 ml). After
the sample application, each SPE column was washed
sequentially with water (3 ml), hexane (1.5 ml), and
chloroform (1.5 ml) to remove salts and other polar
Fig. 1. Mean arterial pressure in AT1A1/1 (j; N 5 9) and AT1A2/2substances, lipids, and hydrophobic materials from the
( ; N 5 8) mice during control (euvolemic) and volume-expandedcolumn. Ang II peptides were eluted from the SPE col-
conditions (N 5 5 experiments each). *P , 0.05 vs. control conditions.
umn twice with 1 ml of 90% methanol in water. The #P , 0.05 vs. AT1A1/1 mice.
eluants were collected and stored at 2208C. Ang II levels
were quantitated by radioimmunoassay using rabbit anti-
Ang II antisera (Arnel, New York, NY, USA), monoio-
RESULTSdinated 125I-labeled Ang II (Amersham, Arlington
Heights, IL, USA), and Ang II standards (Sigma) as The average body weight of the AT1A2/2 mice was
described and validated previously [20–22]. In view of 29.6 6 0.9 g (N 5 16) and was similar to that measured
previous observations that the greatest amount of Ang in the wild-type controls (30.3 6 1.0 g, N 5 17). As has
II-like immunoreactivity on high-performance liquid been reported previously [4, 5, 23], heart weight in the
chromatography (HPLC) coeluted with Ang II, and AT1A2/2 mice was significantly lower than in the
given the high specificity of the Ang II antisera [20, AT1A1/1 mice (128 6 4 vs. 148 6 5 mg); however, kidney
21], the individual plasma, kidney, and heart samples weights were not different (429 6 20 vs. 407 6 11 mg).
obtained in this study were not subjected to HPLC prior Similarly, there were no significant differences in hema-
to radioimmunoassays. tocrits under control conditions between AT1A2/2 mice
Urine volume was determined gravimetrically. Urine and AT1A1/1 mice (47 6 3 vs. 46 6 2%). Volume expan-
and blood inulin and PAH concentrations were deter- sion elicited equivalent decreases in hematocrit in
mined using standard colorimetric techniques. Sodium AT1A2/2 and AT1A1/1 mice (to 32 6 2% and to 33 6
and potassium concentrations in urine and plasma were 3%, respectively).
determined by flame photometry. GFR was calculated The mean arterial pressure (MAP) responses to intra-
from the clearance of inulin. PAH clearance was used venous bolus injections of 100 ng of Ang II averaged
as an index of renal plasma flow (RPF). Filtered sodium 45 6 3 mm Hg (N 5 17) in the AT1A1/1 mice but were
load was calculated as the product of GFR and plasma not discernible in the AT1A2/2 mice. As shown in Figure
sodium concentration, and absolute sodium reabsorption 1, MAP under control conditions was significantly lower
was calculated as the difference between filtered sodium in the AT1A2/2 mice compared with the AT1A1/1 mice
load and absolute urinary sodium excretion. The rela- (68 6 4 vs. 89 6 3 mm Hg). AT1A2/2 mice responded
tionship between filtered sodium load and absolute so- to isotonic saline volume expansion with an increase in
dium reabsorption was calculated using linear regression MAP to levels approaching those found in the AT1A1/1
analysis. Statistical analyses were performed using one- mice (83 6 5 mm Hg). The increases in MAP in the
way analysis of variance and two-way repeated-measures AT1A2/2 mice during volume expansion occurred rap-
analysis of variance with one factor repeated, followed by idly within the first 10 minutes of infusion. In contrast,
Student-Newman-Keuls test. Statistical significance was MAP in the AT1A1/1 mice was not significantly influ-
enced by the volume expansion (92 6 5 mm Hg).defined as P , 0.05. Results are expressed as means 6 se.
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Fig. 3. Absolute sodium excretion in AT1A1/1 (j) and AT1A2/2 ( )
mice during control (N 5 9 and 8, respectively) and volume-expanded
(N 5 5 and 5, respectively) conditions. *P , 0.05 vs. control conditions.
0.1 vs. 0.7 6 0.09 ml/min · g and 3.23 6 0.57 vs. 4.36 6
0.82 ml/min · g, respectively). In the volume-expanded
mice, both GFR (1.16 6 0.12 vs. 1.09 6 0.2 ml/min · g)
and RPF (12.9 6 2.4 vs. 15.5 6 2.0 ml/min · g) were
substantially and significantly greater than those ob-
served during the euvolemic conditions, but the corre-
sponding values in AT1A2/2 and AT1A1/1 mice were
not significantly different from each other.
As shown in Figure 3, despite the lower arterial pres-
sures, control values for absolute sodium excretion were
not significantly different in AT1A1/1 and AT1A2/2
mice (0.16 6 0.03 and 0.1 6 0.06 mmol/min · g, respec-
tively). Volume expansion elicited equivalent increases
in absolute sodium excretion in AT1A1/1 and AT1A2/2
mice (to 3.63 6 0.6 and to 2.75 6 0.69 mmol/min · g).
Similarly, there were no significant differences between
basal values for fractional sodium excretion in the two
groups (0.19 6 0.03 vs. 0.11 6 0.02%), and volume expan-
sion significantly increased fractional sodium excretion
to the same extent in both groups (to 2.12 6 0.29% andFig. 2. Glomerular filtration rate (A) and renal plasma flow (B) in
AT1A1/1 (j) and AT1A2/2 ( ) mice during control (N 5 9 and 8, to 1.86 6 0.35%, respectively).
respectively) and volume-expanded (N 5 5 and 5, respectively) condi-
The plasma concentrations and kidney tissue contentstions. *P , 0.05 vs. control conditions.
of Ang II in AT1A1/1 and AT1A2/2 mice are summa-
rized in Figure 4. Plasma Ang II levels were higher in
the AT1A2/2 mice than in the AT1A1/1 mice (536 6 172
vs. 198 6 36 fmol/ml, P , 0.05), and volume expansionAs shown in Figure 2, the basal values for GFR and
markedly suppressed plasma Ang II levels in theRPF in AT1A2/2 mice were not significantly different
from those in AT1A1/1 mice, although they were numer- AT1A2/2 mice to concentrations not significantly differ-
ent from those observed in the wild-type mice (to 151 6ically lower in association with the lower MAP (0.5 6
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significantly different in the volume-expanded groups in
either AT1A1/1 or AT1A2/2 mice (466 6 155 to 397 6
44 and 248 6 27 to 154 6 27 fmol/g, respectively). In
both control and volume-expanded mice, there was a
trend toward lower intrarenal Ang II concentrations in
the AT1A2/2 mice in the individual subgroups. When
control and volume-expanded mice were considered as
a single group (N 5 15 for each group), kidney Ang II
contents in the AT1A2/2 mice were significantly lower
than in the AT1A1/1 mice (207 6 22 vs. 439 6 83 fmol/g,
P , 0.05). In addition, the ratio between kidney tissue
Ang II content and plasma Ang II levels in the AT1A2/2
mice during control conditions were lower than the cor-
responding values in the AT1A1/1 mice (0.8 6 0.4 vs.
3.3 6 1.2). In contrast, there were no differences in heart
Ang II levels between AT1A1/1 and AT1A2/2 mice
under euvolemic and volume-expanded conditions (515 6
59 vs. 623 6 81, N 5 8 and 9, and 376 6 38, vs. 402 6
108, N 5 6 and 7, fmol/g, respectively).
To evaluate the efficiency of glomerulotubular bal-
ance, the filtered sodium loads were plotted against the
absolute sodium reabsorption rates. As shown in Figure 5,
the relationships demonstrated similar increases in sodium
reabsorption rates in response to increases in filtered load
for the AT1A1/1 mice (r 5 0.97, N 5 14) and for the
AT1A2/2 mice (r 5 0.96, N 5 13). There was no differ-
ence between the slopes of the relations between filtered
sodium load and absolute sodium reabsorption in
AT1A2/2 and the AT1A1/1 mice (0.98 vs. 0.98).
DISCUSSION
One of the prominent features of the phenotype of
AT1A receptor-deficient mice is significant hypotension
with a systolic blood pressure(s) that is 20 to 25 mm
Hg less than controls [4, 5, 23]. Along with the marked
reduction in the pressor effects of Ang II in these ani-
mals, these findings confirm the importance of this recep-
tor in mediating vascular responses to Ang II and in
blood pressure regulation. In this study, volume expan-
sion of approximately 5% of body weight caused rapid
increases of MAP in AT1A2/2 mice to levels similar to
those measured in AT1A1/1 mice. These data indicate
that the reduced basal MAP in AT1A2/2 mice is primar-
Fig. 4. Plasma Ang II levels (A) and kidney Ang II contents (B) in ily due to a reduction in effective blood volume and
AT1A1/1 (j) and AT1A2/2 ( ) mice during control and volume- that this can be readily reversed with adequate volume
expanded conditions. When Ang II contents from control and volume-
replacement. This explanation is supported by recentexpanded mice were analyzed together, kidney Ang II contents in
AT1A2/2 mice were significantly lower (P , 0.05) than in AT1A1/1 findings that AT1A2/2 mice given a mineralocorticoid
mice. *P , 0.05 vs. control conditions. #P , 0.05 vs. AT1A1/1 mice. and salt have arterial blood pressures similar to those
found in AT1A1/1 mice on normal diet [23] and that
high salt intake for three weeks did not alter the arterial
pressure of AT1A1/1 mice, but increased the arterial15 fmol/ml vs. 153 6 30 fmol/ml, P , 0.05); volume
pressure of AT1A2/2 mice to levels similar to those ofexpansion did not significantly alter plasma Ang II levels
AT1A1/1 mice (abstract; Oliverio et al, Hypertensionin the AT1A1/1 mice. In contrast to plasma Ang II levels,
the kidney tissue Ang II contents (Fig. 4B) were not 26:546A, 1998). Despite the hypotension, however, GFR,
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However, it is possible that activation of AT1B and/or
AT2 receptors may have contributed to the maintenance
of normal renal function in the AT1A2/2 mice. Further
studies are required to address this issue. Assuming that
the AT1A2/2 mice exhibit pressure natriuresis, it can be
surmised that sodium excretion in the AT1A2/2 mice
would be much greater at normal arterial pressures and
that the failure of the AT1A2/2 mice to maintain normal
arterial pressure is because of excessive sodium excretion
and associated volume loss due to the absence of func-
tional AT1A receptors [1, 10, 11, 24]. In essence, the lack
of functional AT1A receptors shifts the pressure natriure-
sis relation to the left, thereby allowing the knockouts
to maintain normal rates of salt and water excretion at
hypotensive arterial pressures.
In contrast to our findings that renal function is pre-
served in AT1A receptor-deficient mice, GFR and urine
concentrating ability are significantly reduced in angio-
tensinogen-deficient (Agt2/2) mice [25, 26]. This differ-
ence may be due to the severe renal structural abnormali-
ties in Agt2/2 mice [27], whereas the morphology of
kidney of AT1A2/2 mice is relatively normal [5]. Func-
tional and morphological abnormalities similar to those
in the Agt2/2 mice also develop in the angiotensin-
converting enzyme gene knockout (ACE2/2) mice [28].
One explanation for these differences is that residual
AT1B receptors partially compensate for the absence of
AT1A receptors [6]. This explanation is supported by the
recent findings that AT1B receptors are up-regulated in
vascular smooth muscle cells (VSMCs) of AT1A2/2 mice
[29] and that the kidney phenotype of mice lacking both
AT1A and AT1B receptors is the same as that observed
in Agt2/2 mice [30, 31].
In view of the critical role of Ang II in regulating
tubular sodium reabsorption [1, 13, 14, 32], it would have
been expected that the absence of the dominant AT1A
receptor would have led to an exaggerated natriuresis
in response to acute volume expansion. However, there
were no differences in the rates of sodium excretion
either under euvolemic conditions or in the responses
to volume expansion between AT1A1/1 and AT1A2/2Fig. 5. Relationship between absolute sodium reabsorption and fil-
mice. Furthermore, the increases in filtered sodium loadtered load of sodium in AT1A1/1 mice (A; d; N 5 14) and AT1A2/2
mice (B; s; N 5 13). The slopes of the relationships between filtered caused by the volume expansion were accompanied by
sodium load and absolute sodium reabsorption in the AT1A2/2 mice parallel increases in absolute sodium reabsorption that
were not different from that in the AT1A1/1 mice (0.98 vs. 0.98). were virtually identical in both the AT1A2/2 mice and
the wild-type controls. Thus, glomerulotubular balance
was not disrupted by the absence of AT1A receptors, as
would have been predicted by studies supporting a majorRPF, and sodium excretion under euvolemic conditions
were similar in the AT1A2/2 mice compared with the role for Ang II in mediating glomerulotubular balance
[13, 14]. These results thus indicate that the AT1A recep-AT1A1/1 mice. Thus, even at reduced arterial pressures,
AT1A2/2 mice can maintain renal hemodynamic and tors are not uniquely responsible for the ability of neph-
rons to increase absolute reabsorption rate in responsesodium excretory function within the normal range. Such
well-preserved renal hemodynamic and excretory func- to increases in filtered load (glomerulotubular balance)
during volume expansion. These findings, however, do nottions are likely a reflection of the reduced Ang II-depen-
dent influence on the renal vasculature in the knockouts. completely rule out a role for Ang II in glomerulotubular
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balance because AT1B or AT2 receptors could still be con- renal hemodynamic and excretory function. The restora-
tion of arterial pressure with acute saline volume expan-tributing to glomerulotubular balance in the AT1A2/2
mice. sion in AT1A2/2 mice suggests that this reduced basal
arterial pressure is primarily due to the reduction inThe second major aim of this study was to delineate
the plasma and kidney tissue Ang II levels in AT1A2/2 effective circulating volume that results from the lack of
Ang II-dependent vascular tone coupled with the re-mice under euvolemic and volume expanded conditions.
This observation of high plasma Ang II levels under duced Ang II-dependent influence on sodium reabsorp-
tion. Interestingly, there was not an exaggerated natri-control conditions in the AT1A2/2 mice is in agreement
with a previous study [23] and is consistent with the uresis in the AT1A2/2 mice in response to volume
expansion, indicating that the AT1A receptor is not re-absence of the short-loop negative feedback effect of
AT1A receptor activation on renin secretion and circulat- sponsible for mediating glomerulotubular balance during
increases in filtered load. The observation that volumeing Ang II levels [1]. Thus, these mice are characterized
by renin overproduction [33], as well as elevated circulat- expansion reduced plasma Ang II levels in AT1A2/2
mice but did not alter kidney tissue Ang II content ining Ang II concentrations. Although the lack of this
AT1A-mediated influence on renin release and subse- either group suggests that systemic and intrarenal Ang
II levels are differentially regulated. Furthermore, thequent Ang II production may contribute to the elevated
Ang II concentrations, it is also possible that the elevated reduction in plasma Ang II levels in AT1A2/2 mice by
restoration of arterial pressure and volume demonstratesplasma Ang II levels in AT1A2/2 mice occurred second-
ary to the reduced arterial pressure. This latter possibility a dominant effect of volume and pressure over AT1A
receptor-mediated short-loop feedback in the regulationis supported by the findings that volume expansion in-
creased both arterial pressure and reduced plasma Ang of circulating Ang II concentrations. Additionally, the
lower ratio between kidney Ang II contents and plasmaII concentrations in AT1A2/2 mice to levels similar to
those in the wild-type mice. These results thus support Ang II levels in the AT1A2/2 mice is consistent with an
important role for AT1A receptors in the regulation ofthe concept that the direct and indirect effects of in-
creases in volume and arterial pressure on renin release intrarenal Ang II levels.
and the resultant plasma Ang II levels are dominant
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